MPO and glomerulonephritis: Using this protocol, mice immunized with the S. aureus JH1-derived pSJH101 6PGD391–410 peptide developed glomerulonephritis of similar severity to MPO-immunized mice with elevated albuminuria, glomerular segmental necrosis, and inflammatory cell infiltrates (Fig. 7).